News

What Is The Difference Between TIR And RETA?

TIR, also known as Tirzepatide, works as a dual-receptor agonist. It binds to and activates two key receptors: the GIP receptor and the GLP‑1 receptor. These two pathways work together to regulate metabolic signaling inside the body. This dual-action mechanism is well known and widely explored. It delivers a balanced signaling profile and has been a very popular option for a long time.

 

RETA, or Retatrutide, is an advanced triple-receptor agonist. Beyond GIP and GLP‑1, it additionally activates the glucagon receptor. Adding the glucagon pathway creates a completely different signaling pattern. The three pathways interact together, bringing a stronger and distinct metabolic signal profile compared with TIR.

 

Simply put, the main difference comes down to their target receptors. TIR relies on the dual GIP/GLP‑1 combination, while RETA uses three interrelated receptor pathways. They each have their own unique signaling characteristics, so you can choose based on which profile you are looking for.

You Might Also Like

Send Inquiry